3 great-value LSE dividend stocks I’d consider buying right now

I’m in the mood to buy more dividend stocks but want to look beyond my usual FTSE 100 faves. These three tempt me.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young black colleagues high-fiving each other at work

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There are loads of great FTSE 100 dividend stocks going cheap today, but I keep returning to the same ones.

I’ve spent the summer loading up on wealth manager M&G, insurer and asset manager Legal & General Group and housebuilder Taylor Wimpey, which all yield around 9%. It’s time to cast my net wider. Here are three top value dividend stocks I’ve overlooked but am considering now.

WPP (LSE: WPP) has been in turmoil since powerhouse Martin Sorrell was forced to quit over misconduct charges in 2018, after decades at the firm he helped found.

I’ve been overlooking these

As the world’s largest advertising firm, WPP has been on the front line of recent economic and stock market volatility, plus it had to undergo a huge overhaul at the same. The share price is down 17.88% over five years and 9.57% over 12 months. I think that offers me an opportunity.

WPP now looks good value, trading at 11.64 times earnings. It has a forecast yield of 5.4%, covered 2.4 times by earnings. Operating margins are forecast to rise from 9.4% to a healthier 13.3%. Yet it faces challenges too.

On 26 October it was forced to cut full-year guidance as technology clients cut ad spend, with Q3 revenues falling 5% to £2.84m. WPP should do better when brighter days arrive. I’d consider buying before then, to take advantage of today’s relatively high yield and low valuation.

Meanwhile, in its former incarnation as GlaxoSmithKline, pharmaceutical stock GSK (LSE: GSK) was on my buy list for years. Then the dividend per share got stuck at 80p as CEO Emma Walmsley prioritised investing in R&D to boost its depleted drugs pipeline, and my attention wandered.

A recovery is due

This fallen dividend hero has stripped out consumer division Haleon but is still struggling to achieve lift-off. Its share price is down 2.88% over 12 months. The dividend is on the up though, with a forecast yield of 4.1%, covered 2.6 times by earnings.

In contrast to WPP, GSK enjoyed a positive Q3 with total sales up 10% to £8.15bn as the vaccines segment surged 33%, with total operating profit rocketing 64%. Today could be a good time to hop on board while GSK is still cheap, trading at 10.1 times earnings. It’s back on my buy list.

Finally, here’s a stock I actually have bought lately, but have been trying not to think about too much in case I’m overcome by the urge to sell. I snapped up Dublin-based paper and packaging specialist Smurfit Kappa Group (LSE: SKG) in June as it looked great value and offered a healthy yield and growth prospects.

Food for thought

On 12 September, its shares crashed 10% on news it was combining with US peer WestRock and seeking a New York listing alongside its standard London one. Markets reckon Smurfit overpaid in its desperation to seal the deal. Having absorbed that initial shock, investors are returning. Its shares are up 4.85% in the last week but down 5.91% over one year.

I’m still in the red but holding on in the expectation that the deal will allow Smurfit to access US growtn opportunities. It looks good value trading at 7.32 times earnings and yields 4.31%. I might even consider buying more.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has positions in Legal & General Group Plc, M&g Plc, Smurfit Kappa Group Plc, and Taylor Wimpey Plc. The Motley Fool UK has recommended GSK and M&g Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Investing £10K into this FTSE 100 giant could bag me a second income worth £980

This Fool explains how dividend investing in the right picks could help build a second income stream, as well as…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The Nasdaq just tanked. Here are 3 US growth stocks to consider for an ISA now

These Nasdaq stocks have a lot of potential in the long run and Edward Sheldon believes they could be worth…

Read more »

Investing Articles

Potentially 42% undervalued, is this FTSE 100 company a sleeping giant?

The FTSE 100 is full of opportunities for the patient investor, and I think I may have found one that…

Read more »

Investing Articles

AstraZeneca, a mega-cap growth stock that just got cheaper!

Our writer takes a closer look at this growth stock -- which also happens to be the largest company of…

Read more »

Investing Articles

How I’d invest £5,000 in FTSE growth stocks right now

Sumayya Mansoor explains why she’s bullish about these FTSE growth stocks, and would be willing to buy some shares.

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

ITV shares down after revenue guidance cut in first-half interim results

After releasing results this morning, the ITV share price slumped. But with several metrics looking positive, how will this effect…

Read more »

Investing Articles

This FTSE 100 stock’s down 50%, and a director just bought 8,000 shares

Directors of this blue-chip company have been snapping up a load of its shares. Should I do likewise and buy…

Read more »

Investing Articles

The BT share price is far too cheap, analysts say!

The BT share price fell on Thursday 25 July after the company's Q1 results. Dr James Fox takes a closer…

Read more »